pyrimethamine has been researched along with Basal Ganglia Diseases in 2 studies
Maloprim: contains above 2 cpds
Basal Ganglia Diseases: Diseases of the BASAL GANGLIA including the PUTAMEN; GLOBUS PALLIDUS; claustrum; AMYGDALA; and CAUDATE NUCLEUS. DYSKINESIAS (most notably involuntary movements and alterations of the rate of movement) represent the primary clinical manifestations of these disorders. Common etiologies include CEREBROVASCULAR DISORDERS; NEURODEGENERATIVE DISEASES; and CRANIOCEREBRAL TRAUMA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adam, I | 1 |
| Elbashir, MI | 1 |
| Nath, A | 1 |
| Hobson, DE | 1 |
| Russell, A | 1 |
1 review available for pyrimethamine and Basal Ganglia Diseases
| Article | Year |
|---|---|
Movement disorders with cerebral toxoplasmosis and AIDS.
Topics: Adult; AIDS-Related Opportunistic Infections; Basal Ganglia Diseases; Cerebral Cortex; Chorea; Drug | 1993 |
1 other study available for pyrimethamine and Basal Ganglia Diseases
| Article | Year |
|---|---|
Extrapyramidal syndrome after treatment of falciparum malaria with sulphadoxine-pyrimethamine.
Topics: Adult; Animals; Antimalarials; Basal Ganglia Diseases; Drug Hypersensitivity; Drug Therapy, Combinat | 2004 |